Protein kinase C-dependent control of Bcl-x alternative splicing

Molecular and Cellular Biology

Volumn 27, Issue 24, 2007, Pages 8431-8441

  Revil, Timothée ^a   Toutant, Johanne ^a   Shkreta, Lulzim ^a   Garneau, Daniel ^a   Cloutier, Philippe ^a   Chabot, Benoit ^a,b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL X; PROTEIN BCL XS; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; STAUROSPORINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; BCL-X PROTEIN; CASPASES; CELL LINE, TUMOR; EXONS; HUMANS; ONCOGENE PROTEINS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RECEPTOR PROTEIN-TYROSINE KINASES; REGULATORY SEQUENCES, NUCLEIC ACID; RNA PRECURSORS; RNA SPLICE SITES; STAUROSPORINE;

EID: 37149014737     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00565-07     Document Type: Article

References (98)

1. Aaltonen, V., J. Koivunen, M. Laato, and J. Peltonen. 2006. Heterogeneity of cellular proliferation within transitional cell carcinoma: correlation of protein kinase C alpha/betaI expression and activity. J. Histochem. Cytochem. 54:795-806.
2. An, P., and P. J. Grabowski. 2007. Exon silencing by UAGG motifs in response to neuronal excitation. PLos Biol. 5:e36.
3. Ares, M., Jr. 2007. Sing the genome electric: excited cells adjust their splicing. PLoS Biol. 5:e55.
4. Ayroldi, E., F. D'Adamio, O. Zollo, M. Agostini, R. Moraca, L. Cannarile, G. Migliorati, D. V. Delfino, and C. Riccardi. 1999. Cloning and expression of a short Fas ligand: a new alternatively spliced product of the mouse Fas ligand gene. Blood 94:3456-3467.
5. Ballou, L. R., C. P. Chao, M. A. Holness, S. C. Barker, and R. Raghow. 1992. Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J. Biol. Chem. 267:20044-20050.
6. Belmokhtar, C. A., J. Hillion, and E. Segal-Bendirdjian. 2001. Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene 20:3354-3362.
7. Black, D. L. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72:291-336.
8. Blaustein, M., F. Pelisch, O. A. Coso, M. J. Bissell, A. R. Kornblihtt, and A. Srebrow. 2004. Mammary epithelial-mesenchymal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase. J. Biol. Chem. 279:21029-21037.
9. Blaustein, M., F. Pelisch, T. Tanos, M. J. Munoz, D. Wengier, L. Quadrana, J. R. Sanford, J. P. Muschietti, A. R. Kornblihtt, J. F. Caceres, O. A. Coso, and A. Srebrow. 2005. Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat. Struct. Mol. Biol. 12:1037-1044.
10. Bolduc, L., B. Labrecque, M. Cordeau, M. Blanchette, and B. Chabot. 2001. Dimethyl sulfoxide affects the selection of splice sites. J. Biol. Chem. 276:17597-17602.
11. Cascino, I., G. Papoff, A. Eramo, and G. Ruberti. 1996. Soluble Fas/Apo-1 splicing variants and apoptosis. Front. Biosci. 1:d12-d18.
12. Casciola-Rosen, L. A., D. K. Miller, G. J. Anhalt, and A. Rosen. 1994. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J. Biol. Chem. 269:30757-30760.
13. Chalfant, C. E., B. Ogretmen, S. Galadari, B. J. Kroesen, B. J. Pettus, and Y. A. Hannun. 2001. FAS activation induces dephosphorylation of SR proteins; dependence on the de novo generation of ceramide and activation of protein phosphatase 1. J. Biol. Chem. 276:44848-44855.
14. Chalfant, C. E., K. Rathman, R. L. Pinkerman, R. E. Wood, L. M. Obeid, B. Ogretmen, and Y. A. Hannun. 2002. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J. Biol. Chem. 277:12587-12595.
15. Chang, B. S., A. Kelekar, M. H. Harris, J. E. Harlan, S. W. Fesik, and C. B. Thompson. 1999. The BH3 domain of Bcl-x(S) is required for inhibition of the antiapoptotic function of Bcl-x(L). Mol. Cell. Biol. 19:6673-6681.
16. Charlet, B. N., P. Logan, G. Singh, and T. A. Cooper. 2002. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol. Cell 9:649-658.
17. Cheng, C., M. B. Yaffe, and P. A. Sharp. 2006. A positive feedback loop couples Ras activation and CD44 alternative splicing. Genes Dev. 20:1715-1720.
18. Cheng, E. H., M. C. Wei, S. Weiler, R. A. Flavell, T. W. Mak, T. Lindsten, and S. J. Korsmeyer. 2001. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8:705-711.
19. Cifone, M. G., R. De Maria, P. Roncaioli, M. R. Rippo, M. Azuma, L. L. Lanier, A. Santoni, and R. Testi. 1994. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 180:1547-1552.
20. Degen, W. G., Y. Aarssen, G. J. Pruijn, P. J. Utz, and W. J. van Venrooij. 2000. The fate of U1 snRNP during anti-Fas induced apoptosis: specific cleavage of the U1 snRNA molecule. Cell Death Differ. 7:70-79.
21. Dominski, Z., and R. Kole. 1991. Selection of splice sites in pre-mRNAs with short internal exons. Mol. Cell. Biol. 11:6075-6083.
22. Fischer, U., R. U. Janicke, and K. Schulze-Osthoff. 2003. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 10:76-100.
23. Garneau, D., T. Revil, J. F. Fisette, and B. Chabot. 2005. Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x. J. Biol. Chem. 280:22641-22650.
24. Ghosh, N., N. Patel, K. Jiang, J. E. Watson, J. Cheng, C. E. Chalfant, and D. R. Cooper. 2007. Ceramide-activated protein phosphatase involvement in insulin resistance via Akt, serine/arginine-rich protein 40, and ribonucleic acid splicing in L6 skeletal muscle cells. Endocrinology 148:1359-1366.
25. Ginestier-Verne, C., M. T. Chateau, and J. P. Bureau. 1996. Implication of tyrosine kinases and protein kinase C in dimethyl sulfoxide-induced apoptosis. Anal. Cell Pathol. 11:115-126.
26. Giuliano, M., G. Bellavia, M. Lauricella, A. D'Anneo, B. Vassallo, R. Vento, and G. Tesoriere. 2004. Staurosporine-induced apoptosis in Chang liver cells is associated with down-regulation of Bcl-2 and Bcl-XL. Int. J. Mol. Med. 13:565-571.
27. Graveley, B. R. 2000. Sorting out the complexity of SR protein functions. RNA 6:1197-1211.
28. Green, J., M. Ikram, J. Vyas, N. Patel, C. M. Proby, L. Ghali, I. M. Leigh, E. A. O'Toole, and A. Storey. 2006. Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours. Br. J. Cancer 94:1446-1451.
29. Gromak, N., A. Rideau, J. Southby, A. D. Scadden, C. Gooding, S. Huttelmaier, R. H. Singer, and C. W. Smith. 2003. The PTB interacting protein raver1 regulates alpha-tropomyosin alternative splicing. EMBO J. 22:6356-6364.
30. Guil, S., J. C. Long, and J. F. Caceres. 2006. hnRNP A1 relocalization to the stress granules reflects a role in the stress response. Mol. Cell. Biol. 26:5744-5758.
31. Hannun, Y. A. 1994. The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem. 269:3125-3128.
32. Holland, S. J., M. J. Powell, C. Franci, E. W. Chan, A. M. Friera, R. E. Atchison, J. McLaughlin, S. E. Swift, E. S. Pali, G. Yam, S. Wong, J. Lasaga, M. R. Shen, S. Yu, W. Xu, Y. Hitoshi, J. Bogenberger, J. E. Nor, D. G. Payan, and J. B. Lorens. 2005. Multiple roles for the receptor tyrosine kinase Axl in tumor formation. Cancer Res. 65:9294-9303.
33. Hsieh, Y. C., H. C. Jao, R. C. Yang, H. K. Hsu, and C. Hsu. 2003. Suppression of protein kinase Calpha triggers apoptosis through down-regulation of Bcl-xL in a rat hepatic epithelial cell line. Shock 19:582-587.
34. Huang, Y., T. A. Yario, and J. A. Steitz. 2004. A molecular link between SR protein dephosphorylation and mRNA export. Proc. Natl. Acad. Sci. USA 101:9666-9670.
35. Izquierdo, J. M., N. Majos, S. Bonnal, C. Martinez, R. Castelo, R. Guigo, D. Bilbao, and J. Valcarcel. 2005. Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol. Cell 19:475-484.
36. Johnson, J. M., J. Castle, P. Garrett-Engele, Z. Kan, P. M. Loerch, C. D. Armour, R. Santos, E. E. Schadt, R. Stoughton, and D. D. Shoemaker. 2003. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302:2141-2144.
37. Kim, M. Y., C. Linardic, L. Obeid, and Y. Hannun. 1991. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J. Biol. Chem. 266:484-489.
38. Kobayashi, E., H. Nakano, M. Morimoto, and T. Tamaoki. 1989. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:548-553.
39. Koivunen, J., V. Aaltonen, S. Koskela, P. Lehenkari, M. Laato, and J. Peltonen. 2004. Protein kinase C alpha/beta inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells. Cancer Res. 64:5693-5701.
40. Koivunen, J., V. Aaltonen, and J. Peltonen. 2006. Protein kinase C (PKC) family in cancer progression. Cancer Lett. 235:1-10.
41. Konig, H., H. Ponta, and P. Herrlich. 1998. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator. EMBO J. 17:2904-2913.
42. Lai, M. C., R. I. Lin, and W. Y. Tarn. 2003. Differential effects of hyperphosphorylation on splicing factor SRp55. Biochem. J. 371:937-945.
43. Langzam, L., R. Koren, R. Gal, V. Kugel, A. Paz, A. Farkas, and S. R. Sampson. 2001. Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy. Am. J. Clin. Pathol. 116:377-385.
44. Lazebnik, Y. A., S. H. Kaufmann, S. Desnoyers, G. G. Poirier, and W. C. Earnshaw. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-347.
45. Lee, J.-A., Y. Xing, D. Nguyen, J. Xie, C. J. Lee, and D. L. Black. 2007. Depolarization and CaM kinase IV modulate NMDA receptor splicing through two essential RNA elements. PLoS Biol. 5:e40.
46. Lee, J. Y., Y. A. Hannun, and L. M. Obeid. 1996. Ceramide inactivates cellular protein kinase Calpha. J. Biol. Chem. 271:13169- 13174.
47. Lee, W. P., Y. Liao, D. Robinson, H. J. Kung, E. T. Liu, and M. C. Hung. 1999. Axl-Gas6 interaction counteracts E1A-mediated cell growth suppression and proapoptotic activity. Mol. Cell. Biol. 19:8075-8082.
48. Leirdal, M., and M. Sioud. 1999. Ribozyme inhibition of the protein kinase C alpha triggers apoptosis in glioma cells. Br. J. Cancer 80:1558-1564.
49. Lemaire, R., A. Winne, M. Sarkissian, and R. Lafyatis. 1999. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation. Eur. J. Immunol. 29:823-837.
50. Li, C. Y., J. Y. Chu, J. K. Yu, X. Q. Huang, X. J. Liu, L. Shi, Y. C. Che, and J. Y. Xie. 2004. Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA. Cell Res. 14:473-479.
51. Lindenboim, L., C. Borner, and R. Stein. 2001. Bcl-x(S) can form homodimers and heterodimers and its apoptotic activity requires localization of Bcl-x(S) to the mitochondria and its BH3 and loop domains. Cell Death Differ. 8:933-942.
52. Liscovitch, M. 1992. Crosstalk among multiple signal-activated phospholipases. Trends Biochem. Sci. 17:393-399.
53. Lynch, K. W., and A. Weiss. 2000. A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras. Mol. Cell. Biol. 20:70-80.
54. Martinez-Contreras, R., J. F. Fisette, P. Cloutier, T. Revil, L. Shkreta, and B. Chabot. hnRNP proteins and splicing control. In B. J. Blencowe and B. R. Graveley (ed.), Alternative splicing in the postgenomic era, in press. Landes Bioscience, Austin, TX.
55. Martiny-Baron, G., M. G. Kazanietz, H. Mischak, P. M. Blumberg, G. Kochs, H. Hug, D. Marme, and C. Schachtele. 1993. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268:9194-9197.
56. Massiello, A., J. R. Roesser, and C. E. Chalfant. 2006. SAP155 binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5′ splice site selection of Bcl-x pre-mRNA. FASEB J. 20:1680-1682.
57. Massiello, A., A. Salas, R. L. Pinkerman, P. Roddy, J. R. Roesser, and C. E. Chalfant. 2004. Identification of two RNA cis-elements that function to regulate the 5′ splice site selection of Bcl-x pre-mRNA in response to ceramide. J. Biol. Chem. 279:15799-15804.
58. Matlin, A. J., F. Clark, and C. W. Smith. 2005. Understanding alternative splicing: towards a cellular code. Nat. Rev. Mol. Cell Biol. 6:386-398.
59. Matter, N., P. Herrlich, and H. Konig. 2002. Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 420:691-695.
60. Novoyatleva, T., Y. Tang, I. Rafalska, and S. Stamm. 2006. Pre-mRNA missplicing as a cause of human disease. Prog. Mol. Subcell. Biol. 44:27-46.
61. O'Brian, C. A., R. M. Liskamp, D. H. Solomon, and I. B. Weinstein. 1985. Inhibition of protein kinase C by tamoxifen. Cancer Res. 45:2462-2465.
62. Okazaki, T., R. M. Bell, and Y. A. Hannun. 1989. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J. Biol. Chem. 264:19076-19080.
63. Paronetto, M. P., T. Achsel, A. Massiello, C. E. Chalfant, and C. Sette. 2007. The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x. J. Cell Biol. 176:929-939.
64. Patel, N. A., S. Kaneko, H. S. Apostolatos, S. S. Bae, J. E. Watson, K. Davidowitz, D. S. Chappell, M. J. Birnbaum, J. Q. Cheng, and D. R. Cooper. 2005. Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40. J. Biol. Chem. 280:14302- 14309.
65. Patel, N. A., S. S. Song, and D. R. Cooper. 2006. PKCdelta alternatively spliced isoforms modulate cellular apoptosis in retinoic acid-induced differentiation of human NT2 cells and mouse embryonic stem cells. Gene Expr. 13:73-84.
66. Pecci, A., L. R. Viegas, J. L. Baranao, and M. Beato. 2001. Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene. J. Biol. Chem. 276:21062-21069.
67. Pelisch, F., M. Blaustein, A. R. Kornblihtt, and A. Srebrow. 2005. Cross-talk between signaling pathways regulates alternative splicing: a novel role for JNK. J. Biol. Chem. 280:25461-25469.
68. Pilch, B., E. Allemand, M. Facompre, C. Bailly, J. F. Riou, J. Soret, and J. Tazi. 2001. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Res. 61:6876-6884.
69. Pollock, A. S., J. Turck, and D. H. Lovett. 2003. The prodomain of interleukin 1alpha interacts with elements of the RNA processing apparatus and induces apoptosis in malignant cells. FASEB J. 17:203-213.
70. Prasad, J., K. Colwill, T. Pawson, and J. L. Manley. 1999. The protein kinase Clk/Sty directly modulates SR protein activity: both hyper- and hypophosphorylation inhibit splicing. Mol. Cell. Biol. 19:6991-7000.
71. Quintans, J., J. Kilkus, C. L. McShan, A. R. Gottschalk, and G. Dawson. 1994. Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation. Biochem. Biophys. Res. Commun. 202:710-714.
72. Rosenberger, U., I. Lehmann, C. Weise, P. Franke, F. Hucho, and K. Buchner. 2002. Identification of PSF as a protein kinase Calpha-binding protein in the cell nucleus. J. Cell Biochem. 86:394-402.
73. Rothrock, C., B. Cannon, B. Hahm, and K. W. Lynch. 2003. A conserved signal-responsive sequence mediates activation-induced alternative splicing of CD45. Mol. Cell 12:1317-1324.
74. Rothrock, C. R., A. E. House, and K. W. Lynch. 2005. HnRNP L represses exon splicing via a regulated exonic splicing silencer. EMBO J. 24:2792-2802.
75. Ruegg, U. T., and G. M. Burgess. 1989. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol. Sci. 10:218-220.
76. Sanford, J. R., D. Longman, and J. F. Caceres. 2003. Multiple roles of the SR protein family in splicing regulation. Prog. Mol. Subcell. Biol. 31:33-58.
77. Savickiene, J., A. Gineitis, and T. Stigbrand. 1999. Modulation of apoptosis of proliferating and differentiating HL-60 cells by protein kinase inhibitors: suppression of PKC or PKA differently affects cell differentiation and apoptosis. Cell Death Differ. 6:698-709.
78. Schwerk, C., and K. Schulze-Osthoff. 2005. Regulation of apoptosis by alternative pre-mRNA splicing. Mol. Cell 19:1-13.
79. Shankar, S. L., K. O'Guin, M. Kim, B. Varnum, G. Lemke, C. F. Brosnan, and B. Shafit-Zagardo. 2006. Gas6/Axl signaling activates the phosphatidylinositol 3-kinase/Akt1 survival pathway to protect oligodendrocytes from tumor necrosis factor alpha-induced apoptosis. J. Neurosci. 26:5638-5648.
80. Shi, Y., B. Reddy, and J. L. Manley. 2006. PP1/PP2A phosphatases are required for the second step of Pre-mRNA splicing and target specific snRNP proteins. Mol. Cell 23:819-829.
81. Shieh, Y. S., C. Y. Lai, Y. R. Kao, S. G. Shiah, Y. W. Chu, H. S. Lee, and C. W. Wu. 2005. Expression of axl in lung adenocarcinoma and correlation with tumor progression. Neoplasia 7:1058-1064.
82. Shin, C., and J. L. Manley. 2004. Cell signalling and the control of pre-mRNA splicing. Nat. Rev. Mol. Cell Biol. 5:727-738.
83. Shiroki, K., A. Yamakawa, M. Shibata, T. Takenawa, S. Sugano, and A. Nomoto. 1992. Adenovirus E1A proteins stimulate inositol phospholipid metabolism in PC12 cells. J. Virol. 66:6093-6098.
84. Smith, C. W., and J. Valcarcel. 2000. Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem. Sci. 25:381-388.
85. Srebrow, A., and A. R. Kornblihtt. 2006. The connection between splicing and cancer. J. Cell Sci. 119:2635-2641.
86. Stepczynska, A., K. Lauber, I. H. Engels, O. Janssen, D. Kabelitz, S. Wesselborg, and K. Schulze-Osthoff. 2001. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene 20:1193-1202.
87. Tacke, R., Y. Chen, and J. L. Manley. 1997. Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer. Proc. Natl. Acad. Sci. USA 94:1148-1153.
88. ten Dam, G. B., C. F. Zilch, D. Wallace, B. Wieringa, P. C. Beverley, L. G. Poels, and G. R. Screaton. 2000. Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors. J. Immunol. 164:5287-5295.
89. van der Houven van Oordt, W., M. T. Diaz-Meco, J. Lozano, A. R. Krainer, J. Moscat, and J. F. Caceres. 2000. The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. J. Cell Biol. 149:307-316.
90. van Ginkel, P. R., R. L. Gee, R. L. Shearer, L. Subramanian, T. M. Walker, D. M. Albert, L. F. Meisner, B. C. Varnum, and A. S. Polans. 2004. Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Res. 64:128-134.
91. Varga, A., G. Czifra, B. Tallai, T. Nemeth, I. Kovacs, L. Kovacs, and T. Biro. 2004. Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas. Eur. Urol. 46:462-465.
92. Viegas, L. R., G. P. Vicent, J. L. Baranao, M. Beato, and A. Pecci. 2004. Steroid hormones induce bcl-X gene expression through direct activation of distal promoter P4. J. Biol. Chem. 279:9831-9839.
93. Wu, J. Y., H. Tang, and N. Havlioglu. 2003. Alternative pre-mRNA splicing and regulation of programmed cell death. Prog. Mol. Subcell. Biol. 31:153-185.
94. Yang, H., M. R. Sadda, M. Li, Y. Zeng, L. Chen, W. Bae, X. Ou, M. T. Runnegar, J. M. Mato, and S. C. Lu. 2004. S-adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: role of protein phosphatase 1 and Bcl-x(S). Hepatology 40:221-231.
95. Yang, X., M. R. Bani, S. J. Lu, S. Rowan, Y. Ben-David, and B. Chabot. 1994. The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5′ splice site selection in vivo. Proc. Natl. Acad. Sci. USA 91:6924-6928.
96. Zhang, W., S. Zheng, P. Storz, and W. Min. 2005. Protein kinase D specifically mediates apoptosis signal-regulating kinase 1-JNK signaling induced by H2O2 but not tumor necrosis factor. J. Biol. Chem. 280:19036-19044.
97. Zhang, X. D., S. K. Gillespie, and P. Hersey. 2004. Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways. Mol. Cancer Ther. 3:187-197.
98. Zinck, R., M. A. Cahill, M. Kracht, C. Sachsenmaier, R. A. Hipskind, and A. Nordheim. 1995. Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol. Cell. Biol. 15:4930-4938.